Search Results

Displaying Results 26-50 of 91 "'CRT'"

Mar 30, 2026, 19:25 ET Vale Base Metals Releases 2025 Exploration and 2026 Outlook Results; Copper Mineral Reserves and Mineral Resources Increase 6% to 53 million tonnes

from 123m55m @0.76% from 390m, inc. 13m @ 1.05% Cu from 432m75m @ 1.34% Cu from 596m, inc. 11m @ 2.71% Cu from 609m (drillhole CRT-CRTS-DH00001)

More news about: Vale Base Metals


Mar 30, 2026, 18:26 ET Vale Base Metals Releases 2025 Exploration and 2026 Outlook Results; Copper Mineral Reserves and Mineral Resources Increase 6% to 53 million tonnes

from 123m55m @0.76% from 390m, inc. 13m @ 1.05% Cu from 432m75m @ 1.34% Cu from 596m, inc. 11m @ 2.71% Cu from 609m (drillhole CRT-CRTS-DH00001)

More news about: Vale Base Metals


Mar 26, 2026, 09:32 ET CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0

February 2026, as monotherapy for adults with unresectable Stage III NSCLC whose disease has not progressed following platinum-based chemoradiotherapy (CRT). With these approvals, sugemalimab has become one of only two anti-PD-(L)1 antibodies approved in both the EU and U.K. for Stage III NSCLC, positioning

More news about: CStone Pharmaceuticals


Mar 23, 2026, 09:00 ET Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

LBB area, when connected to a transvenous ICD or CRT-D, such as the Medtronic Cobalt™ and Crome™ family of devices. Patients indicated for CRT may benefit when OmniaSecure is paired with a left ventricular coronary sinus lead (i.e., biventricular or LOT-CRT configurations). For patients who do not require

More news about: Medtronic plc


Mar 20, 2026, 08:00 ET CROSS TIMBERS ROYALTY TRUSTDECLARES MARCH CASH DISTRIBUTION

March 20, 2026 /PRNewswire/ -- Argent Trust Company, as Trustee of the Cross Timbers Royalty Trust (the "Trust") (NYSE: CRT), today declared a cash distribution to the holders of its units of beneficial interest of $0.000923 per unit, payable on April 14, 2026, to unitholders

More news about: Cross Timbers Royalty Trust


Mar 07, 2026, 16:00 ET Late-Breaking Clinical Trial Presentation of the First-Ever US Cohort of Over 4,000 CathWorks FFRangio Patients Demonstrates Similar Clinical Outcomes to Invasive Pressure Wire-Guided PCI through 2 Years

WASHINGTON, March 7, 2026 /PRNewswire/ -- Today at the Cardiovascular Research Technologies (CRT) annual conference taking place in Washington, DC, Dr. Christopher Chieh Yang Koo from National University Hospital Singapore, on behalf of investigators

More news about: CathWorks


Feb 26, 2026, 10:45 ET Cardiac Monitoring & Cardiac Rhythm Management Devices Market worth $37.88 billion by 2031 | MarketsandMarkets™

due to the high prevalence of conditions such as atrial fibrillation and ventricular arrhythmias, coupled with the widespread use of pacemakers, ICDs, CRT systems, and advanced monitoring devices for timely detection and treatment.By pacemakers, Leadless pacemakers are expected to register the

More news about: MarketsandMarkets


Feb 22, 2026, 19:10 ET CStone Announces MHRA Approval in UK for Sugemalimab in Stage III NSCLC

and no sensitising EGFR mutations, or ALK, ROS1 genomic aberrations and whose disease has not progressed following platinum-based chemoradiotherapy (CRT). Dr. Jason Yang, CEO, President of R&D, and Executive Director at CStone, stated, "Since its initial EU approval in July 2024, sugemalimab

More news about: CStone Pharmaceuticals


Feb 17, 2026, 14:36 ET /C O R R E C T I O N -- Cross Timbers Royalty Trust/

Feb. 17, 2026 /PRNewswire/ -- Argent Trust Company, as Trustee of the Cross Timbers Royalty Trust (the "Trust") (NYSE: CRT), today declared a cash distribution to the holders of its units of beneficial interest of $0.050060 per unit, payable on March 13, 2026, to unitholders

More news about: Cross Timbers Royalty Trust


Feb 12, 2026, 06:33 ET BIOTRONIK launcht weltweit erstes CRT-D-System mit Zulassung für Stimulation des Reizleitungssystems

bekannt, die die weltweit ersten ICD- und CRT-D-Implantate mit CE-Zulassung für die Stimulation in der Linksschenkel-Region (LBBAP) umfasst. Diese implantierbaren Kardioverter–Defibrillatoren (ICDs) und Defibrillatoren zur kardialen Resynchronisationstherapie (CRT–Ds) der nächsten Generation sind jetzt in

More news about: Biotronik


Feb 12, 2026, 06:07 ET BIOTRONIK lanza los primeros sistemas DAI tricamerales del mundo para el ritmo cardiaco

fue realizado en el Hospital Universitario de Fráncfort por la Dra. Anastasia Falagkari y el Prof. Dr. Reza Wakili. El equipo implantó el dispositivo CRT–D Rivacor Sky HF–T en un paciente de 87 años con miocardiopatía isquémica que requería un DAI, con antecedentes de fibrilación auricular y una previsión

More news about: Biotronik


Feb 12, 2026, 05:27 ET BIOTRONIK Expands Cardiac Rhythm Care by Launching World's First CRT-D Systems Approved for Conduction System Pacing

provides more physiologic and synchronized heart contractions, which is exactly what we aim for in resynchronization therapy. The CRT-DX technology allows a dual-lead CRT approach, contributing to a more efficient implantation procedure. In addition, based on the two-lead-only approach it is very likely

More news about: Biotronik


Feb 02, 2026, 10:08 ET El Texas Cardiac Arrhythmia Institute en el Centro Médico de St. David es el primero en los EE. UU. en implantar un nuevo cable de desfibrilación aprobado por la FDA

especializado y aislado que se conecta a un desfibrilador cardioversor implantable (ICD) o a un dispositivo de terapia de resincronización cardíaca (CRT-Ds) en el corazón y corrige el ritmo anormal. El cable de desfibrilación es el cable de desfibrilación administrado por catéter más pequeño del mundo,

More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center


Feb 02, 2026, 09:44 ET Teksański Instytut Arytmii Serca przy Centrum Medycznym St. David's jako pierwszy w USA wszczepia nową elektrodę defibrylacyjną zatwierdzoną przez FDA

przewodu, który łączy się z wszczepialnym kardiowerterem-defibrylatorem (ICD) lub urządzeniem do terapii resynchronizującej serce z funkcją defibrylacji (CRT-D) i koryguje zaburzenia rytmu serca. Jest to najmniejsza na świecie elektrodą defibrylacyjna wprowadzana za pomocą cewnika, co umożliwia jej precyzyjne

More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center


Feb 02, 2026, 09:08 ET Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to implant FDA-approved novel defibrillation lead

defibrillation lead—a specialized, insulated wire that connects to an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT-Ds) device to the heart and corrects abnormal rhythm. The defibrillation lead is the world's smallest, catheter-delivered defibrillation lead, which allows

More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center


Feb 02, 2026, 07:08 ET Texas Cardiac Arrhythmia Institute at St. David's Medical Center primeiro nos EUA a implantar novo eletrodo de desfibrilação aprovado pela FDA

fio isolado especializado que se conecta a um desfibrilador cardioversor implantável (ICD) ou dispositivo de terapia de ressincronização cardíaca (CRT-Ds) no coração e corrige o ritmo anormal. O eletrodo de desfibrilação é o menor eletrodo de desfibrilação fornecido por cateter do mundo, que permite

More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center


Feb 02, 2026, 04:08 ET Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to implant FDA-approved novel defibrillation lead

defibrillation lead—a specialized, insulated wire that connects to an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT-Ds) device to the heart and corrects abnormal rhythm. The defibrillation lead is the world's smallest, catheter-delivered defibrillation lead, which allows

More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center


Feb 02, 2026, 03:08 ET Texaský inštitút srdcových arytmií v St. David's Medical Center ako prvý v USA implantuje novú defibrilačnú elektródu schválenú FDA

izolovaný drôt, ktorý sa pripája k implantovateľnému kardioverteru-defibrilátoru (ICD) alebo zariadeniu na resynchronizačnú terapiu s defibrilátorom (CRT-D) so srdcom a koriguje abnormálny rytmus. Defibrilačná elektróda je najmenšia defibrilačná elektróda na svete, ktorá sa zavádza katétrom. Umožňuje presné

More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center


Feb 02, 2026, 03:08 ET Texaský institut pro srdeční arytmii v St. David's Medical Center jako první v USA implantoval novou defibrilační elektrodu schválenou FDA

speciální izolovaný vodič, který se připojuje k implantabilnímu kardioverteru-defibrilátoru (ICD) nebo zařízení pro resynchronizační terapii srdce (CRT-D) a koriguje abnormální rytmus. Defibrilační elektroda je nejmenší defibrilační elektroda na světě zaváděná katétrem, která umožňuje přesné zavedení

More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center


Feb 02, 2026, 03:08 ET Texas Cardiac Arrhythmia Institute am St. David's Medical Center implantiert als erstes in den USA die von der FDA zugelassene neuartige Defibrillationselektrode

spezieller, isolierter Draht, der mit einem implantierbaren Kardioverter-Defibrillator (ICD) oder einem Gerät für die kardiale Resynchronisationstherapie (CRT-Ds) am Herzen verbunden wird und den abnormalen Rhythmus korrigiert. Die Defibrillationselektrode ist die weltweit kleinste, über einen Katheter eingebrachte

More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center


Feb 02, 2026, 03:08 ET TCAI del Centro Médico St. David's implanta un novedoso cable de desfibrilación aprobado por la FDA

especializado que se conecta al corazón con un desfibrilador cardioversor implantable (DCI) o un dispositivo de terapia de resincronización cardíaca (CRT-D) y corrige el ritmo cardíaco anormal. Este cable de desfibrilación es el más pequeño del mundo, administrado por catéter, lo que permite una colocación

More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center


Feb 02, 2026, 03:08 ET Le Texas Cardiac Arrhythmia Institute du St. David's Medical Center est le premier aux États-Unis à implanter une nouvelle sonde de défibrillation approuvée par la FDA

isolé spécialisé qui se connecte à un défibrillateur cardioverteur implantable (ICD) ou à un dispositif de thérapie de resynchronisation cardiaque (CRT-Ds) dans le cœur et corrige le rythme anormal. La sonde de défibrillation est la plus petite sonde de défibrillation délivrée par cathéter au monde, ce

More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center


Feb 02, 2026, 01:08 ET Техасский институт сердечной аритмии, расположенный в Медицинском центре Св. Дэвида, первым в США имплантировал одобренный FDA новый дефибрилляционный электрод

изолированный провод, который подключается к имплантируемому кардиовертеру-дефибриллятору (ICD) или устройству сердечной ресинхронизирующей терапии (CRT-D) и корректирует ненормальный ритм. Данный дефибрилляционный электрод является самым маленьким в мире и точно доставляется через катетер и имплантируется

More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center


Feb 01, 2026, 22:38 ET Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to implant FDA-approved novel defibrillation lead

defibrillation lead—a specialized, insulated wire that connects to an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT-Ds) device to the heart and corrects abnormal rhythm. The defibrillation lead is the world's smallest, catheter-delivered defibrillation lead, which allows

More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center


Feb 01, 2026, 21:08 ET Pertama di AS, Texas Cardiac Arrhythmia Institute di St. David's Medical Center mengimplan elektroda Defibrilator Kardioverter Implan (ICD) baru yang disetujui oleh FDA.

FDA, yakni kabel berinsulasi khusus yang terhubung ke perangkat Implantable Cardioverter Defibrillator (ICD) atau Cardiac Resynchronization Therapy (CRT-Ds) ke jantung dan memperbaiki irama yang tidak normal. Elektroda defibrilasi ini terkecil di dunia dan dilakukan melalui kateter untuk pemberian dan

More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.